August 2004 โ Taxotere was approved for use in combination with doxorubicin and cyclophosphamide for the adjuvant treatment of women with operable node-positive breast cancer.
Reference: Martins, Ines. โDocetaxel (Taxotere).โ Breast Cancer News, 19 Apr. 2016, breastcancer-news.com/docetaxel-taxotere/